Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Clinical trial NCT05637515 · COMPLETED

Trial details

NCT number: NCT05637515
Sponsor: Biocon Biologics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate Chronic Plaque Psoriasis Severe Chronic Plaque Psoriasis

Start date: 2022-11-21
Primary completion: 2023-09-19
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.